1
|
Langman EL, Johnson KS, Dinome ML. Retained Biopsy Site Markers After Breast Lesion Surgical Resection: Associations With Residual Malignancy. AJR Am J Roentgenol 2024; 222:e2329670. [PMID: 37646391 DOI: 10.2214/ajr.23.29670] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 09/01/2023]
Abstract
BACKGROUND. Biopsy site markers (BSMs) placed during image-guided core needle biopsy (CNB) are typically targeted for surgical excision, along with the breast imaging abnormality. Retained BSMs raise concern of incomplete resection of the breast abnormality. OBJECTIVE. The purpose of our study was to assess the frequency of residual malignancy in patients with retained BSMs identified on the initial mammography performed after breast lesion surgical excision. METHODS. This retrospective study included 30 patients (median age, 59 years) who underwent surgical resection between August 2015 and April 2022 of a borderline, high-risk, or malignant breast lesion after CNB and technically adequate preoperative image-guided localization, in whom the initial postoperative mammography report described a retained nonmigrated BSM. EMR data were extracted. The index pathology from CNB and initial surgical resection was classified as malignant or nonmalignant. The presence of residual malignancy after initial surgical resection required pathologic confirmation from subsequent tissue sampling; the absence of residual malignancy required 2 years of benign imaging follow-up. RESULTS. Thirteen specimen radiographs were interpreted intraoperatively by a surgeon with later radiologist interpretation, and 17 underwent real-time radiologist interpretation. Eighteen patients had malignant index pathology from the initially resected lesion. The frequency of residual malignancy on subsequent follow-up after initial surgical resection was higher in patients with malignant than nonmalignant index pathology (39% [7/18] vs 0% [0/12], respectively; p = .02). Among patients with malignant index pathology, the frequency of residual malignancy was higher in those without, than with, malignancy in the initial surgical specimen (80% [4/5] vs 23% [3/13]; p = .047). Also in these patients, the frequency of a positive interpretation of the initial postoperative mammography (BI-RADS category 4 or 6) was not significantly different between those with and without residual malignancy (57% [4/7] vs 55% [6/11]; p > .99). CONCLUSION. Patients with retained BSMs associated with malignant index lesions are at substantial risk of having residual malignancy. Initial postoperative mammography is not sufficient for excluding residual malignancy. CLINICAL IMPACT. Retained BSMs associated with index malignancy should be considered suspicious for residual malignancy. In this scenario, timely additional tissue sampling targeting the retained BSM is warranted, given the greater-than-2% chance of malignancy. Active surveillance is a reasonable management strategy in patients with retained BSMs from nonmalignant index lesions.
Collapse
Affiliation(s)
- Eun L Langman
- Department of Radiology, Duke University Medical Center, 2301 Erwin Rd, Box 3808, Durham, NC 27710
| | - Karen S Johnson
- Department of Radiology, Duke University Medical Center, 2301 Erwin Rd, Box 3808, Durham, NC 27710
| | - Maggie L Dinome
- Department of Surgery, Duke University School of Medicine, Durham, NC
| |
Collapse
|
2
|
Jani C, Lotz M, Keates S, Gupta Y, Walker A, Al Omari O, Parvez A, Patel D, Gnata M, Perry J, Khorashadi L, Weissmann L, Pories SE. Management of Lobular Neoplasia Diagnosed by Core Biopsy. Breast J 2023; 2023:8185446. [PMID: 37114120 PMCID: PMC10129432 DOI: 10.1155/2023/8185446] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/04/2022] [Revised: 03/05/2023] [Accepted: 04/08/2023] [Indexed: 04/29/2023]
Abstract
Lobular neoplasia (LN) involves proliferative changes within the breast lobules. LN is divided into lobular carcinoma in situ (LCIS) and atypical lobular hyperplasia (ALH). LCIS can be further subdivided into three subtypes: classic LCIS, pleomorphic LCIS, and LCIS with necrosis (florid type). Because classic LCIS is now considered as a benign etiology, current guidelines recommend close follow-up with imaging versus surgical excision. The goal of our study was to determine if the diagnosis of classic LN on core needle biopsy (CNB) merits surgical excision. This is a retrospective, observational study conducted at Mount Auburn Hospital, Cambridge, MA, from May 17, 2017, through June 30, 2020. We reviewed the data of breast biopsies conducted at our hospital over this period and included patients who were diagnosed with classic LN (LCIS and/or ALH) and excluded patients having any other atypical lesions on CNB. All known cancer patients were excluded. Of the 2707 CNBs performed during the study period, we identified 68 women who were diagnosed with ALH or LCIS on CNB. CNB was performed for an abnormal mammogram in the majority of patients (60; 88%) while 7(10.3%) had an abnormal breast magnetic resonance imaging study (MRI), and 1 had an abnormal ultrasound (US). A total of 58 patients (85%) underwent excisional biopsy, of which 3 (5.2%) showed malignancy, including 2 cases of DCIS and 1 invasive carcinoma. In addition, there was 1 case (1.7%) with pleomorphic LCIS and 11 cases with ADH (15.5%). The management of LN found on core biopsy is evolving, with some advocating surgical excision and others recommending observation. Our data show a change in diagnosis with excisional biopsy in 13 (22.4%) of patients with 2 cases of DCIS, 1 invasive carcinoma, 1 pleomorphic LCIS, and 9 cases of ADH, diagnosed on excisional biopsy. While ALH and classic LCIS are considered benign, the choice of ongoing surveillance versus excisional biopsy should be made with shared decision making with the patient, with consideration of personal and family history, as well as patient preferences.
Collapse
Affiliation(s)
- Chinmay Jani
- Department of Internal Medicine, Mount Auburn Hospital, 300 Mount Auburn St., Cambridge, MA, USA
- Harvard Medical School, 25 Shattuck St, Boston 02115, MA, USA
| | - Margaret Lotz
- Harvard Medical School, 25 Shattuck St, Boston 02115, MA, USA
- Division of Hematology-Oncology, Mount Auburn Hospital, 300 Mount Auburn St., Cambridge, MA, USA
- Hoffman Breast Center, Department of Surgery, Mount Auburn Hospital, 300 Mount Auburn St., Cambridge, MA, USA
| | - Sarah Keates
- Harvard Medical School, 25 Shattuck St, Boston 02115, MA, USA
- Division of Hematology-Oncology, Mount Auburn Hospital, 300 Mount Auburn St., Cambridge, MA, USA
- Hoffman Breast Center, Department of Surgery, Mount Auburn Hospital, 300 Mount Auburn St., Cambridge, MA, USA
| | - Yasha Gupta
- Harvard Medical School, 25 Shattuck St, Boston 02115, MA, USA
- Department of Radiology, Mount Auburn Hospital, 300 Mount Auburn St., Cambridge, MA, USA
| | - Alexander Walker
- Department of Internal Medicine, Mount Auburn Hospital, 300 Mount Auburn St., Cambridge, MA, USA
- Harvard Medical School, 25 Shattuck St, Boston 02115, MA, USA
| | - Omar Al Omari
- Department of Internal Medicine, Mount Auburn Hospital, 300 Mount Auburn St., Cambridge, MA, USA
- Harvard Medical School, 25 Shattuck St, Boston 02115, MA, USA
| | - Arshi Parvez
- Department of Internal Medicine, Mount Auburn Hospital, 300 Mount Auburn St., Cambridge, MA, USA
- Harvard Medical School, 25 Shattuck St, Boston 02115, MA, USA
| | - Dipesh Patel
- Harvard Medical School, 25 Shattuck St, Boston 02115, MA, USA
- Department of Radiology, Mount Auburn Hospital, 300 Mount Auburn St., Cambridge, MA, USA
| | - Maria Gnata
- Hoffman Breast Center, Department of Surgery, Mount Auburn Hospital, 300 Mount Auburn St., Cambridge, MA, USA
| | - John Perry
- Department of Pathology, Mount Auburn Hospital, 300 Mount Auburn St., Cambridge, MA, USA
| | - Leila Khorashadi
- Harvard Medical School, 25 Shattuck St, Boston 02115, MA, USA
- Department of Radiology, Mount Auburn Hospital, 300 Mount Auburn St., Cambridge, MA, USA
| | - Lisa Weissmann
- Department of Internal Medicine, Mount Auburn Hospital, 300 Mount Auburn St., Cambridge, MA, USA
- Harvard Medical School, 25 Shattuck St, Boston 02115, MA, USA
- Division of Hematology-Oncology, Mount Auburn Hospital, 300 Mount Auburn St., Cambridge, MA, USA
| | - Susan E. Pories
- Harvard Medical School, 25 Shattuck St, Boston 02115, MA, USA
- Hoffman Breast Center, Department of Surgery, Mount Auburn Hospital, 300 Mount Auburn St., Cambridge, MA, USA
| |
Collapse
|
3
|
Malinaric R, Balzarini F, Granelli G, Ferrari A, Trani G, Ambrosini F, Mantica G, Panarello D, De Rose AF, Terrone C. From women to women—hematuria during therapy for metastatic breast cancer, what to suspect and when to be alarmed; Bladder metastasis from breast cancer—our experience and a systematic literature review. Front Oncol 2022; 12:976947. [PMID: 36248976 PMCID: PMC9557997 DOI: 10.3389/fonc.2022.976947] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/23/2022] [Accepted: 08/31/2022] [Indexed: 11/13/2022] Open
Abstract
Breast cancer is one of the most important causes of premature mortality in women worldwide. Around 12% of breast cancer patients will develop metastatic disease, a stage associated with poor prognosis, and only 26% of patients are likely to survive for at least 5 years after being diagnosed. Although the most common sites where breast cancer tends to spread are bones, lungs, brain, and liver, it is important that physicians consider other less frequent organs and viscera, like the bladder, as a target destination. In this article we report our experience with this rare form of metastases and a systematic literature review. We analyzed case reports, case series, and review articles present in PubMED/MEDLINE up to March 2022. We excluded the nonrelevant articles, editorials, letters to the editor, and articles written in other languages. We identified a total of 302 articles, with 200 articles being removed before screening; therefore, the total number of abstracts reviewed was 102. Fifty-five articles were excluded before full text review because they did not meet the inclusion criteria, and one article was not retrievable. Therefore, we included a total of 45 articles in this review. The intention of this review is to highlight the importance of the early detection of bladder metastases and to facilitate the diagnostic process for the responsible physician. The most common signs and symptoms and breast cancer subtype associated with bladder metastases, as well as overall survival after their detection, were all assessed. Bladder metastases from metastatic breast cancer are prevalent in the invasive, lobular breast cancer subtype; most patients present with hematuria (39.5%) and the relative 5-year survival rate is 2%. The main limitations of this review are the low number of cases reported in the literature, clinical and pathological differences between the individual cases, and absence of the control group. This study was not funded.
Collapse
Affiliation(s)
- Rafaela Malinaric
- Department of Urology, L'Istituto di ricovero e cura a carattere scientifico (IRCCS) Ospedale Policlinico San Martino, Genova, Italy
- Department of Surgical and Diagnostic Integrated Sciences (DISC), University of Genova, Genova, Italy
- *Correspondence: Rafaela Malinaric,
| | - Federica Balzarini
- Department of Urology, L'Istituto di ricovero e cura a carattere scientifico (IRCCS) Ospedale Policlinico San Martino, Genova, Italy
- Department of Surgical and Diagnostic Integrated Sciences (DISC), University of Genova, Genova, Italy
| | - Giorgia Granelli
- Department of Urology, L'Istituto di ricovero e cura a carattere scientifico (IRCCS) Ospedale Policlinico San Martino, Genova, Italy
- Department of Surgical and Diagnostic Integrated Sciences (DISC), University of Genova, Genova, Italy
| | - Arianna Ferrari
- Department of Urology, L'Istituto di ricovero e cura a carattere scientifico (IRCCS) Ospedale Policlinico San Martino, Genova, Italy
- Department of Surgical and Diagnostic Integrated Sciences (DISC), University of Genova, Genova, Italy
| | - Giorgia Trani
- Department of Urology, L'Istituto di ricovero e cura a carattere scientifico (IRCCS) Ospedale Policlinico San Martino, Genova, Italy
- Department of Surgical and Diagnostic Integrated Sciences (DISC), University of Genova, Genova, Italy
| | - Francesca Ambrosini
- Department of Urology, L'Istituto di ricovero e cura a carattere scientifico (IRCCS) Ospedale Policlinico San Martino, Genova, Italy
- Department of Surgical and Diagnostic Integrated Sciences (DISC), University of Genova, Genova, Italy
| | - Guglielmo Mantica
- Department of Urology, L'Istituto di ricovero e cura a carattere scientifico (IRCCS) Ospedale Policlinico San Martino, Genova, Italy
| | - Daniele Panarello
- Department of Urology, L'Istituto di ricovero e cura a carattere scientifico (IRCCS) Ospedale Policlinico San Martino, Genova, Italy
| | - Aldo Franco De Rose
- Department of Urology, L'Istituto di ricovero e cura a carattere scientifico (IRCCS) Ospedale Policlinico San Martino, Genova, Italy
| | - Carlo Terrone
- Department of Urology, L'Istituto di ricovero e cura a carattere scientifico (IRCCS) Ospedale Policlinico San Martino, Genova, Italy
- Department of Surgical and Diagnostic Integrated Sciences (DISC), University of Genova, Genova, Italy
| |
Collapse
|